These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 38774880)

  • 21. Targeting the programmed cell death (PCD) signaling mechanism with natural substances for the treatment of diabetic cardiomyopathy (DCM).
    Xuan X; Zhang S
    Phytother Res; 2023 Dec; 37(12):5495-5508. PubMed ID: 37622685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting non-coding RNAs in sEVs: The biological functions and potential therapeutic strategy of diabetic cardiomyopathy.
    Ding N; Yin Z; Chen C
    Biomed Pharmacother; 2023 Jul; 163():114836. PubMed ID: 37156118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate.
    Al Hroob AM; Abukhalil MH; Hussein OE; Mahmoud AM
    Biomed Pharmacother; 2019 Jan; 109():2155-2172. PubMed ID: 30551473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginsenoside RG1-induced mesenchymal stem cells alleviate diabetic cardiomyopathy through secreting exosomal circNOTCH1 to promote macrophage M2 polarization.
    Zhen J; Bai J; Liu J; Men H; Yu H
    Phytother Res; 2024 Apr; 38(4):1745-1760. PubMed ID: 37740455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.
    Yang F; Qin Y; Wang Y; Li A; Lv J; Sun X; Che H; Han T; Meng S; Bai Y; Wang L
    Cell Physiol Biochem; 2018; 50(4):1230-1244. PubMed ID: 30355944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Puerarin Inhibits NLRP3-Caspase-1-GSDMD-Mediated Pyroptosis via P2X7 Receptor in Cardiomyocytes and Macrophages.
    Sun S; Gong D; Liu R; Wang R; Chen D; Yuan T; Wang S; Xing C; Lv Y; Du G; Fang L
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Insight into the Pathogenesis of Diabetic Cardiomyopathy Along with the Novel Potential Therapeutic Approaches.
    Vig H; Ravinandan AP; Vishwas HN; Tyagi S; Rathore S; Wal A; Wal P
    Curr Diabetes Rev; 2024; 20(1):e020523216416. PubMed ID: 37138437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isosteviol ameliorates diabetic cardiomyopathy in rats by inhibiting ERK and NF-κB signaling pathways.
    Tang SG; Liu XY; Ye JM; Hu TT; Yang YY; Han T; Tan W
    J Endocrinol; 2018 Jul; 238(1):47-60. PubMed ID: 29720537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of mitochondrial dysfunction in diabetic cardiomyopathy and intervention of traditional Chinese medicine].
    Tian J; Lv R; Guo W
    Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(1):8-14. PubMed ID: 29552805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antioxidative Effects of Natural Products on Diabetic Cardiomyopathy.
    Yan B; Ren J; Zhang Q; Gao R; Zhao F; Wu J; Yang J
    J Diabetes Res; 2017; 2017():2070178. PubMed ID: 29181412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory Serine Proteases Play a Critical Role in the Early Pathogenesis of Diabetic Cardiomyopathy.
    Kolpakov MA; Sikder K; Sarkar A; Chaki S; Shukla SK; Guo X; Qi Z; Barbery C; Sabri A; Rafiq K
    Cell Physiol Biochem; 2019; 53(6):982-998. PubMed ID: 31829530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (Pro)renin Receptor RNA Interference Silencing Attenuates Diabetic Cardiomyopathy Pathological Process in Rats.
    Yu S; Yuan H; Yang M; Cao X; Chen J; Zhou X; Dong B
    Hum Gene Ther; 2019 Jun; 30(6):727-739. PubMed ID: 30632404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking.
    Zhu N; Huang B; Zhu L; Wang Y
    J Diabetes Res; 2021; 2021():9944589. PubMed ID: 34926700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cinnamic acid is beneficial to diabetic cardiomyopathy via its cardioprotective, anti-inflammatory, anti-dyslipidemia, and antidiabetic properties.
    Nair A; Preetha Rani MR; Salin Raj P; Ranjit S; Rajankutty K; Raghu KG
    J Biochem Mol Toxicol; 2022 Dec; 36(12):e23215. PubMed ID: 36117386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling.
    Ding W; Feng H; Li WJ; Liao HH; Zhang N; Zhou ZY; Mou SQ; Lin Z; Xia-He NZ; Xia H; Tang QZ
    Eur J Pharmacol; 2021 Oct; 909():174402. PubMed ID: 34348125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NORAD lentivirus shRNA mitigates fibrosis and inflammatory responses in diabetic cardiomyopathy via the ceRNA network of NORAD/miR-125a-3p/Fyn.
    Liu Y; Zhu Y; Liu S; Liu J; Li X
    Inflamm Res; 2021 Dec; 70(10-12):1113-1127. PubMed ID: 34591118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astraglaus polysaccharide protects diabetic cardiomyopathy by activating NRG1/ErbB pathway.
    Chang X; Lu K; Wang L; Lv M; Fu W
    Biosci Trends; 2018 May; 12(2):149-156. PubMed ID: 29607874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective.
    Tian J; Zhao Y; Liu Y; Liu Y; Chen K; Lyu S
    Oxid Med Cell Longev; 2017; 2017():8214541. PubMed ID: 29204251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress.
    Huang Y; Zhang J; Xu D; Peng Y; Jin Y; Zhang L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats.
    Trang NN; Chung CC; Lee TW; Cheng WL; Kao YH; Huang SY; Lee TI; Chen YJ
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.